Antivirals and neutralising monoclonal antibodies in the treatment of Covid-19 in hospitalised Patients
A COVID-19 therapeutic alert has been issued: neutralising monoclonal antibodies (nMABs) and antivirals for treatment of Covid-19 hospitalised patients.
The policy has been updated to reflect the wit
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news
More News: COVID-19 | Drugs & Pharmacology